Zacks Premium Empowers Investors with Confidence in Stock Market
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Should l Buy SYK?
Source: NASDAQ.COM
- Investor Confidence Boost: Zacks Premium offers daily updates on Zacks Rank and Industry Rank, aiding investors in making informed decisions, thereby enhancing confidence and optimizing their portfolios.
- Style Score System: The Zacks Style Scores evaluate stocks based on value, growth, and momentum characteristics, helping investors identify stocks with the potential to outperform the market over the next 30 days, thus enhancing the effectiveness of investment strategies.
- Strong Earnings Forecast: Stryker Corporation (SYK) is projected to achieve a year-over-year growth rate of 9.4% for fiscal 2024, with a Zacks Rank of #2 (Buy), indicating robust growth potential that attracts investor interest.
- Expert Stock Recommendations: Five Zacks experts have each selected a stock expected to skyrocket over 100% in the coming months, further boosting investor confidence and engagement in the market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SYK?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SYK
Wall Street analysts forecast SYK stock price to rise
20 Analyst Rating
17 Buy
3 Hold
0 Sell
Strong Buy
Current: 332.070
Low
390.00
Averages
430.32
High
465.00
Current: 332.070
Low
390.00
Averages
430.32
High
465.00
About SYK
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Intuitive Surgical: Advantages of a Market Leader
- Market Share Advantage: Intuitive Surgical holds an impressive 86% share of the U.S. robotic surgical systems market, and despite facing competition, its dominance in soft tissue procedures continues to yield excellent financial results, making it attractive for long-term investors.
- Financial Flexibility: As of 2025, Intuitive Surgical reported total assets of $20.5 billion against total liabilities of $2.5 billion, with a minimal percentage of long-term debt, providing the company with significant financial stability and flexibility during economic fluctuations.
- Increased Competitive Pressure: With Medtronic's Hugo system and Johnson & Johnson's Ottava system nearing approval, Intuitive Surgical will encounter heightened market competition; however, its high switching costs and proven success over two decades will help maintain its market leadership.
- Sustained Growth Potential: Despite intensifying industry competition, Intuitive Surgical's market remains underpenetrated, and with its leading market share and high customer loyalty, the company is well-positioned for continued stable financial growth in the future.
See More
Analysis of VUG ETF's 52-Week Price Fluctuations
- Price Range Analysis: The VUG ETF has a 52-week low of $323.795 and a high of $505.38, with the latest trade at $439.12, indicating stability within its volatility range, which aids investors in assessing market performance.
- Technical Analysis Tool: Comparing the current share price to the 200-day moving average provides valuable technical insights for investors, helping to gauge market trends and potential buying opportunities.
- ETF Trading Mechanism: ETFs trade similarly to stocks, where investors buy and sell 'units' that can be created or destroyed based on investor demand, impacting the fund's liquidity and market performance.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in shares outstanding for ETFs highlights those experiencing significant inflows or outflows, which can affect the underlying stocks held within the ETFs and influence overall market dynamics.
See More
Zacks Premium Empowers Investors with Confidence in Stock Market
- Investor Confidence Boost: Zacks Premium offers daily updates on Zacks Rank and Industry Rank, aiding investors in making informed decisions, thereby enhancing confidence and optimizing their portfolios.
- Style Score System: The Zacks Style Scores evaluate stocks based on value, growth, and momentum characteristics, helping investors identify stocks with the potential to outperform the market over the next 30 days, thus enhancing the effectiveness of investment strategies.
- Strong Earnings Forecast: Stryker Corporation (SYK) is projected to achieve a year-over-year growth rate of 9.4% for fiscal 2024, with a Zacks Rank of #2 (Buy), indicating robust growth potential that attracts investor interest.
- Expert Stock Recommendations: Five Zacks experts have each selected a stock expected to skyrocket over 100% in the coming months, further boosting investor confidence and engagement in the market.
See More
The Evolving Dynamics of a Market During Wartime
Market Impact of Iran Conflict: The ongoing Iran war has led to a correction in U.S. stock markets, with the Dow Jones Industrial Average experiencing its longest losing streak since May 2022, as investors grapple with the potential for a prolonged conflict and rising oil prices.
Cybersecurity Threats: U.S. companies, particularly in the tech sector, are facing increased cyberattacks linked to Iranian state-backed groups, which could disrupt operations and erode consumer trust, while also drawing attention to vulnerabilities in critical infrastructure.
Fertilizer Supply Concerns: The conflict has caused a significant rise in fertilizer prices and raised concerns about supply shortages for the upcoming planting season, potentially impacting crop yields and food prices globally.
Geopolitical Developments: Ongoing tensions in Ukraine and delayed U.S.-China talks highlight the complex geopolitical landscape, with implications for trade and international relations as the U.S. navigates multiple global conflicts.
See More
Stryker Restores Most Manufacturing Operations After Cyberattack
- Manufacturing Recovery: Stryker has quickly restored most of its manufacturing capabilities following a cyberattack, stating that “manufacturing capability is quickly ramping with most of our sites and critical lines restored,” which will help alleviate order delays caused by the attack.
- Cyberattack Impact: The cyberattack, claimed by the pro-Palestinian hacking group Handala, severely disrupted Stryker's global information systems and business applications, impacting order processing, manufacturing, and shipping, forcing healthcare providers to delay surgeries involving Stryker products.
- Employee Scale and Market Position: Based in Michigan, Stryker employs nearly 56,000 people and is a leading manufacturer of surgical robots, orthopedic equipment, and implants, highlighting its significance in the medical device industry and the cybersecurity risks it faces.
- Stock Price Recovery: Following the announcement of restored manufacturing capabilities, Stryker's shares ended a seven-day decline, reflecting market confidence in its operational recovery despite the significant impact of the cyberattack.
See More
Stryker Corporation Announces 2026 Annual Shareholders Meeting Schedule
- Meeting Schedule: Stryker Corporation has scheduled its 2026 Annual Meeting of Shareholders for May 6, 2026, at 12:00 p.m. Eastern Time, to be held virtually, facilitating global shareholder participation.
- Webcast Information: The meeting will be available via webcast, including audio and slide presentations, with details accessible on the company's Investor Relations page, enhancing transparency and shareholder engagement.
- Recording Availability: A recording of the meeting will be available from 10:30 a.m. Eastern Time on May 7, 2026, until the definitive proxy statement for the 2027 Annual Meeting is filed, ensuring shareholders can access the meeting content at their convenience.
- Company Overview: Stryker is a global leader in medical technologies, impacting over 150 million patients annually, and is committed to improving healthcare outcomes through innovative products and services, highlighting its strategic significance in the healthcare sector.
See More
Intuitive Surgical: Advantages of a Market Leader
- Market Share Advantage: Intuitive Surgical holds an impressive 86% share of the U.S. robotic surgical systems market, and despite facing competition, its dominance in soft tissue procedures continues to yield excellent financial results, making it attractive for long-term investors.
- Financial Flexibility: As of 2025, Intuitive Surgical reported total assets of $20.5 billion against total liabilities of $2.5 billion, with a minimal percentage of long-term debt, providing the company with significant financial stability and flexibility during economic fluctuations.
- Increased Competitive Pressure: With Medtronic's Hugo system and Johnson & Johnson's Ottava system nearing approval, Intuitive Surgical will encounter heightened market competition; however, its high switching costs and proven success over two decades will help maintain its market leadership.
- Sustained Growth Potential: Despite intensifying industry competition, Intuitive Surgical's market remains underpenetrated, and with its leading market share and high customer loyalty, the company is well-positioned for continued stable financial growth in the future.
See More
Analysis of VUG ETF's 52-Week Price Fluctuations
- Price Range Analysis: The VUG ETF has a 52-week low of $323.795 and a high of $505.38, with the latest trade at $439.12, indicating stability within its volatility range, which aids investors in assessing market performance.
- Technical Analysis Tool: Comparing the current share price to the 200-day moving average provides valuable technical insights for investors, helping to gauge market trends and potential buying opportunities.
- ETF Trading Mechanism: ETFs trade similarly to stocks, where investors buy and sell 'units' that can be created or destroyed based on investor demand, impacting the fund's liquidity and market performance.
- Inflows and Outflows Monitoring: Weekly monitoring of changes in shares outstanding for ETFs highlights those experiencing significant inflows or outflows, which can affect the underlying stocks held within the ETFs and influence overall market dynamics.
See More
Zacks Premium Empowers Investors with Confidence in Stock Market
- Investor Confidence Boost: Zacks Premium offers daily updates on Zacks Rank and Industry Rank, aiding investors in making informed decisions, thereby enhancing confidence and optimizing their portfolios.
- Style Score System: The Zacks Style Scores evaluate stocks based on value, growth, and momentum characteristics, helping investors identify stocks with the potential to outperform the market over the next 30 days, thus enhancing the effectiveness of investment strategies.
- Strong Earnings Forecast: Stryker Corporation (SYK) is projected to achieve a year-over-year growth rate of 9.4% for fiscal 2024, with a Zacks Rank of #2 (Buy), indicating robust growth potential that attracts investor interest.
- Expert Stock Recommendations: Five Zacks experts have each selected a stock expected to skyrocket over 100% in the coming months, further boosting investor confidence and engagement in the market.
See More
The Evolving Dynamics of a Market During Wartime
Market Impact of Iran Conflict: The ongoing Iran war has led to a correction in U.S. stock markets, with the Dow Jones Industrial Average experiencing its longest losing streak since May 2022, as investors grapple with the potential for a prolonged conflict and rising oil prices.
Cybersecurity Threats: U.S. companies, particularly in the tech sector, are facing increased cyberattacks linked to Iranian state-backed groups, which could disrupt operations and erode consumer trust, while also drawing attention to vulnerabilities in critical infrastructure.
Fertilizer Supply Concerns: The conflict has caused a significant rise in fertilizer prices and raised concerns about supply shortages for the upcoming planting season, potentially impacting crop yields and food prices globally.
Geopolitical Developments: Ongoing tensions in Ukraine and delayed U.S.-China talks highlight the complex geopolitical landscape, with implications for trade and international relations as the U.S. navigates multiple global conflicts.
See More
Stryker Restores Most Manufacturing Operations After Cyberattack
- Manufacturing Recovery: Stryker has quickly restored most of its manufacturing capabilities following a cyberattack, stating that “manufacturing capability is quickly ramping with most of our sites and critical lines restored,” which will help alleviate order delays caused by the attack.
- Cyberattack Impact: The cyberattack, claimed by the pro-Palestinian hacking group Handala, severely disrupted Stryker's global information systems and business applications, impacting order processing, manufacturing, and shipping, forcing healthcare providers to delay surgeries involving Stryker products.
- Employee Scale and Market Position: Based in Michigan, Stryker employs nearly 56,000 people and is a leading manufacturer of surgical robots, orthopedic equipment, and implants, highlighting its significance in the medical device industry and the cybersecurity risks it faces.
- Stock Price Recovery: Following the announcement of restored manufacturing capabilities, Stryker's shares ended a seven-day decline, reflecting market confidence in its operational recovery despite the significant impact of the cyberattack.
See More
Stryker Corporation Announces 2026 Annual Shareholders Meeting Schedule
- Meeting Schedule: Stryker Corporation has scheduled its 2026 Annual Meeting of Shareholders for May 6, 2026, at 12:00 p.m. Eastern Time, to be held virtually, facilitating global shareholder participation.
- Webcast Information: The meeting will be available via webcast, including audio and slide presentations, with details accessible on the company's Investor Relations page, enhancing transparency and shareholder engagement.
- Recording Availability: A recording of the meeting will be available from 10:30 a.m. Eastern Time on May 7, 2026, until the definitive proxy statement for the 2027 Annual Meeting is filed, ensuring shareholders can access the meeting content at their convenience.
- Company Overview: Stryker is a global leader in medical technologies, impacting over 150 million patients annually, and is committed to improving healthcare outcomes through innovative products and services, highlighting its strategic significance in the healthcare sector.
See More
